Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc ICOTF


Primary Symbol: T.MSCL Alternate Symbol(s):  MSCLF

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).


TSX:MSCL - Post by User

Bullboard Posts
Post by moneystarvedon May 10, 2013 4:49pm
158 Views
Post# 21364816

Moving Forward

Moving Forward

That was painful, but we survived.  In fact, I added a decent amount to my position today.

That should be the last of the pain (I hope), now its step by step until efficacy results (and spec run up to then).

I am sure a lot of long term holders are pretty angry, but all we can do is look forward now.   We now have enough money to get through to the endpoint, and hold the cards for any negotiations with regional deals and/or larger buy out.  We didnt want people holding us ransom, knowing our funds were running on empty.

Management....please keep a flow of news coming in from here on out.    These swings suck......but the story/treatment and potential has not changed.  The only thing that has changed is that we now have solid financial ground to maneuver.

**Rumz...as much as I hate to say it....you were right (I should have gotten out...then back in today.  Although I am not in this one to trade in and out...we will all be rewarding in the end)!

Good luck to all!

Bullboard Posts